Finance

Lists
NXGN:TLV
Nextgen Biomed Ltd
ILA 45,00
0,00%
(0,00) 1D
20 Mei, 17:24:52 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXGN...
Mkt. cap
10,11 m
Avg. vol.
0,00
Volume
0,00
52-wk high
ILA 62,00
52-wk low
ILA 37,60
Shares outstanding
22,48 m
No. of employees
3
Mkt. cap
10,11 m
Avg. vol.
0,00
Volume
0,00
52-wk high
ILA 62,00
52-wk low
ILA 37,60
Shares outstanding
22,48 m
No. of employees
3
News stories
From web sources and news partners
About Nextgen Biomed Ltd
CEO-
Employees3
Founded1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in ILS
Sep. 2024
Des. 2024
Mrt. 2025
Jun. 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
231,00 k
231,00 k
146,50 k
146,50 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,23 m
1,23 m
816,50 k
816,50 k
Operating expense
1,60 m
1,60 m
3,71 m
3,71 m
Total operating expenses
1,60 m
1,60 m
3,71 m
3,71 m
Operating income
-1,60 m
-1,60 m
-3,71 m
-3,71 m
Other non operating income
-
-
-
-
EBT including unusual items
-1,59 m
-1,59 m
-3,85 m
-3,85 m
EBT excluding unusual items
-1,59 m
-1,59 m
-3,85 m
-3,85 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
131,50 k
131,50 k
2,75 m
2,75 m
Net income
-1,59 m
-1,59 m
-3,18 m
-3,18 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,00 k
2,00 k
15,00 k
15,00 k
Interest expense
-500,00
-500,00
-149,50 k
-149,50 k
Net interest expenses
1,50 k
1,50 k
-134,50 k
-134,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,56 m
-1,56 m
-3,67 m
-3,67 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme